Form 4: AbbVie Director Susan E. Quaggin Reports Acquisition of Restricted Stock Units

Director Susan E. Quaggin reports acquisition of 1,203 restricted stock units in AbbVie Inc.

Summary

• On May 9, 2025, Susan E. Quaggin, a director of AbbVie Inc., acquired 1,203 restricted stock units (RSUs) under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These RSUs will be paid out in shares of AbbVie common stock on a one-to-one basis upon the director's separation from service, death, or a change in control.
• Following the transaction, Quaggin directly owns 2,525 shares of AbbVie common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral as it reports a standard transaction of stock units to a director. It's a routine filing and doesn't indicate any significant positive or negative implications for the company.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control as defined in the Program.

Industry Context

This filing is a routine disclosure of stock-based compensation to a company director, which is a common practice in publicly traded companies to align the interests of management with those of shareholders.

Stakeholder Impact

• The acquisition of restricted stock units by a director aligns their interests with those of shareholders, potentially incentivizing them to work towards the company's long-term success.

Key Dates

Keywords

AbbVie, Director, Stock Units, RSU, Form 4, Beneficial Ownership, Incentive Stock Program